DRI developed intelligence that certain international narcotic drugs and psychotropic substances trafficking and smuggling organized syndicates had set-up manufacturing facilities in India to manufacture, sell and illicitly export banned synthetic drugs, such as Ketamine.

These persons were key members of an international syndicate which had close linkages in South-East Asia and Canada.